Cambridge, MA, United States of America

Lampros Kourtis

This inventor holds 22 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in Polymer Engineering. Top assignees: Hyalex Orthopaedics, Inc., Biomimedica, Inc., Eli Lilly and Company. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lampros Kourtis. Retrieved from https://idiyas.com/inventor/lampros-kourtis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 86.4

 

 

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 134(Granted Patents)


Location History:

  • Berkeley, CA (US) (2014)
  • San Francisco, CA (US) (2013 - 2017)
  • Cambridge, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Polymeric Adhesive
Hydrogels
Orthopedic Implants
Ionic Polymer Compositions
Interpenetrating Polymer Networks
Gradient Polymer Alloys
Drug Delivery Devices
Status Sensing System
Hydrophobic Polymers
Polyurethane-grafted Hydrogels
Anchoring Systems
Arthroplasty Device
22 patents (USPTO):Explore Patents

Title: Innovations of Lampros Kourtis: Pioneering Medical Technology in Cambridge

Introduction: Lampros Kourtis, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of medical technology with an impressive portfolio of 20 patents. His groundbreaking work focuses on developing innovative solutions for orthopedic applications and injection systems that enhance patient care and safety.

Latest Patents: Among Kourtis's latest patents, two stand out for their potential impact on medical practices. The first patent, titled "Polymeric adhesive for anchoring compliant materials to another surface," outlines methods, compositions, and kits for adhering polymers to bone or bone-like structures. This composition features a unique urethane dimethacrylate-methyl methacrylate copolymer designed to improve the attachment of orthopedic joint implants. The application method includes using precursors and an initiator to create a strong adhesive copolymer that ensures the implant's durability in the joint space.

The second patent, "Status sensing system for injection device," introduces a sophisticated assembly designed for improved functionality and patient safety during injections. This innovative device includes a housing, syringe, drive mechanism, and an advanced status sensing system capable of determining various conditions during an injection process. This system features a light emitter and detector working together to assess the current status, providing crucial information on the injection's readiness and execution.

Career Highlights: Lampros Kourtis has demonstrated a relentless pursuit of innovation throughout his career. He has held positions at notable companies such as Hyalex Orthopaedics, Inc. and Biomimedica, Inc., where he contributed to the advancement of medical devices and technologies. His ability to bridge the gap between engineering and medicine has allowed him to develop solutions that address critical challenges in patient treatment.

Collaborations: Kourtis has collaborated with talented professionals in his field, including David Myung and Michael J. Jaasma. Their combined expertise has fostered a creative environment conducive to significant breakthroughs in medical technology, underscoring the importance of teamwork in the innovation process.

Conclusion: Lampros Kourtis exemplifies the spirit of innovation, demonstrating how a dedicated inventor can make meaningful contributions to healthcare. His patents reflect a commitment to improving medical procedures and patient outcomes, solidifying his position as a thought leader in the industry. As advancements in medical technology continue, Kourtis's work will undoubtedly play a vital role in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…